GEEV Trademark

Trademark Overview

On Thursday, August 5, 2021, a trademark application was filed for GEEV with the United States Patent and Trademark Office. The USPTO has given the GEEV trademark a serial number of 79322364. The federal status of this trademark filing is REGISTERED as of Tuesday, February 14, 2023. This trademark is owned by SillaJen, Inc.. The GEEV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals for the prevention, diagnosis and treatment of cancer; pharmaceutical preparations based on a genetically engineered poxvirus platform used in the prevention, diagnosis and treatment of cancer
geev

General Information

Serial Number79322364
Word MarkGEEV
Filing DateThursday, August 5, 2021
Status700 - REGISTERED
Status DateTuesday, February 14, 2023
Registration Number6976289
Registration DateTuesday, February 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements

Goods and ServicesPharmaceutical products and drug delivery platforms in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals for the prevention, diagnosis and treatment of cancer; pharmaceutical preparations based on a genetically engineered poxvirus platform used in the prevention, diagnosis and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSillaJen, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR
Party NameSillaJen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR
Party NameSillaJen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Sunday, January 28, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 12, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 17, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 17, 2023FINAL DISPOSITION PROCESSED
Sunday, May 14, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 14, 2023REGISTERED-PRINCIPAL REGISTER
Monday, December 12, 2022NOTIFICATION PROCESSED BY IB
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 23, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 7, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, October 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 5, 2022REFUSAL PROCESSED BY IB
Saturday, June 11, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 11, 2022REFUSAL PROCESSED BY MPU
Saturday, May 7, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 6, 2022NON-FINAL ACTION WRITTEN
Thursday, May 5, 2022ASSIGNED TO EXAMINER
Saturday, October 16, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, October 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 8, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

geev cancer treatment pharmaceutical delivery diagnosis prevention preparations genetically used platform